← Back to Search

Procedure

Cordotomy for Cancer Pain Management

N/A
Recruiting
Led By Eduardo Bruera
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Unilateral pain due to cancer below the shoulder level (arm, trunk, hip, leg)
Has undergone 3 palliative care evaluations
Must not have
Uncorrectable coagulopathy
Large intracranial mass
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
Approved for 5 Other Conditions
All Individual Drugs Already Approved

Summary

This trial studies how well cordotomy works in reducing severe pain in patients with advanced cancer. Cordotomy involves using a needle to make a small cut in the spinal cord, which helps block pain signals from reaching the brain. The goal is to see if this method can effectively reduce pain when other treatments don't work. Cordotomy has been used since 1912 and has evolved from a more invasive open surgical procedure to a less invasive percutaneous radiofrequency procedure.

Who is the study for?
This trial is for advanced cancer patients with pain intensity of 4 or higher on a scale of 0-10, specifically below the shoulder level. Participants must have had three palliative care evaluations and be able to consent. Those who can't complete forms, have less than a month to live, issues with blood clotting, sedation risks, brain tumors or morphine allergies cannot join.
What is being tested?
The study tests if cordotomy—a needle procedure on the spinal cord guided by CT scans—can reduce severe cancer-related pain better than standard treatments like morphine. Patients will also answer questionnaires about their pain levels.
What are the potential side effects?
Cordotomy may cause discomfort at the injection site, potential nerve damage leading to weakness or numbness, and risks associated with sedation. Morphine's side effects include drowsiness, constipation, nausea and potential dependency.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have cancer-related pain in one side of my body below the shoulder.
Select...
I have had three evaluations for symptom management and support.
Select...
My pain level is 4 or higher on a scale of 0 to 10.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a blood clotting disorder that cannot be corrected.
Select...
I have a large brain tumor.
Select...
I cannot have medicines that make me sleep through an IV.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Reduction in pain intensity
Secondary study objectives
Brief Pain Inventory pain interference items
Other ESAS symptoms

Awards & Highlights

Approved for 5 Other Conditions
This treatment demonstrated efficacy for 5 other conditions.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Group I (cordotomy)Experimental Treatment2 Interventions
Patients undergo a cordotomy over 1-2 hours.
Group II: Group II (morphine, fake cordotomy)Placebo Group3 Interventions
Patients receive morphine via injection into the spine and undergo a fake cordotomy over 1-2 hours.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cordotomy
2015
N/A
~20

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Cordotomy is a surgical procedure that interrupts pain pathways in the spinal cord, providing relief for cancer patients with severe, refractory pain. This is particularly important for those with advanced cancer, as it can significantly improve their quality of life. Other treatments, such as radiation therapy, work by shrinking tumors that cause pain through pressure on nerves or bones. Pharmacologic approaches, including opioids and adjuvant analgesics, modulate pain perception at different points in the nervous system. Understanding these mechanisms allows for personalized pain management strategies, enhancing patient comfort and daily functioning.
Surgical cordotomy helps psychosocial suffering.Minimally Invasive Cordotomy for Refractory Cancer Pain: A Randomized Controlled Trial.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,917 Previous Clinical Trials
41,014,426 Total Patients Enrolled
M.D. Anderson Cancer CenterLead Sponsor
3,065 Previous Clinical Trials
1,802,182 Total Patients Enrolled
National Institute of Nursing Research (NINR)NIH
600 Previous Clinical Trials
10,377,731 Total Patients Enrolled

Media Library

Cordotomy (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04119037 — N/A
Cancer Research Study Groups: Group II (morphine, fake cordotomy), Group I (cordotomy)
Cancer Clinical Trial 2023: Cordotomy Highlights & Side Effects. Trial Name: NCT04119037 — N/A
Cordotomy (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04119037 — N/A
~5 spots leftby Sep 2025